Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study.
Marios C PantzarisChristos BakirtzisNikolaos GrigoriadisGeorgios HadjigeorgiouEfthimos DardiotisGeorge LoucaidesEvangelia NtzaniGeorgios MarkozannesSavvas OmorfosPaola ValsasinaRoberta MessinaPaolo PreziosaMaria Assunta RoccaIoannis PatrikiosPublished in: BMJ neurology open (2022)
ISRCTN06166891.